Redesign Science is a computational drug discovery company focusing on lead discovery against challenging and emerging drug targets, including protein-protein interactions. Their platform technology uses dynamic simulation at the atomic level to detect druggability and to guide the precise molecular design of novel therapeutic candidates.

The startup represented here is a graduate of Endless Frontier Labs’ predecessor program, called Creative Destruction Lab-New York City, operated by NYU in partnership with University of Toronto during 2018-2019. The Endless Frontier Labs has no current engagement or affiliation with the Creative Destruction Lab.